Actovegin in the management of patients after ischemic stroke: A systematic review.

Philip la Fleur Ardak BaizhaxynovaEmily ReynenDavid KaunelisDinara Galiyeva

Published in: PloS one (2022)

The benefits of Actovegin are uncertain and that there is potential risk of harm in patients with stroke. More evidence is needed from rigorously designed clinical trials to justify the role of Actovegin in patients with ischemic stroke.

Keyphrases

atrial fibrillation
clinical trial
study protocol
open label
climate change